Actions and Detail Panel
CARE Congress on Biosimilars
Fri, 13 January 2017, 11:30 AM – 5:00 PM EST
Date: Friday, January 13th, 2017
Time: 11:30 - 5:00 pm
Location: Marriott Hotel, Toronto Eaton Centre
Steering faculty: Dr. John Marshall (CARE Gastroenterology Faculty, McMaster University)
Dr. John Kuruvilla (CARE Hematology Faculty, Princess Margaret Cancer Centre)
About the CARE Congress on Biosimilars:
This congress will be led by a panel of multiple CARE faculty in the field of gastroenterology, oncology, hematology and rheumatology. The CARE faculty will facilitate a speaker line up that will include clinicians, nurses, hospital pharmacists, health Canada, ethicists, medical legal, patient advocacy groups and payers to share their understanding and position regarding the integration of biosimilars in the Canadian healthcare system.
The congress will be open to a diverse audience of multiple specialties including but not limited to hematology, oncology, gastroenterology, rheumatology, respirology, and dermatology. This audience will be comprised of physicians, patient’s groups, pharmacists, nurses, payers, members of government and sponsoring industry.
Biologic and Biosimilar Basic Science
Clinical Data Review
Health Canada Perspective
Patient Advocacy Perspectives
Legal and Ethical Considerations
Steering Faculty Bio's:
John Marshall, MD. MSc, FRCPC, AGAF
Professor, Department of Medicine, McMaster University
Member, Fancombe Family Digestive Health Research Institute
Head, Clinical Research for the Division of Gastroenterology
Dr. Marshall is a Professor of Medicine at McMaster University and Chief of Service for Gastroenterology at Hamilton Health Sciences in Hamilton, Ontario. He completed his B.A. and M.D. at Queen’s University, and then undertook his residency training and M.Sc. in Clinical Epidemiology & Biostatistics at McMaster University. He is a Full Member of the Farncombe Family Digestive Health Research Institute. His publications include over 180 academic papers and book chapters and over 200 abstracts. He is currently Co-Editor-in-Chief of the Canadian Journal of Gastroenterology and Hepatology, an Associate Editor of ACP Journal Club and Evidence-Based Medicine, an Editorial Board Member for the Journal of Crohn’s and Colitis and Clinical Gastroenterology and Hepatology, and an Editor for the Cochrane Collaboration Inflammatory Bowel Disease and Functional Bowel Disorders Review Group. Honours include the Canadian Association of Gastroenterology (CAG) Young Investigator Award (2008), the CAG Young Educator Award (2006) and Fellowship in the American Gastroenterological Association (2007). Dr. Marshall’s clinical and research interests include inflammatory bowel disease, post-infectious irritable bowel syndrome, gastrointestinal bleeding, endoscopy, clinical trials, clinical epidemiology, health outcomes and health economics.
John Kuruvilla, MD, FRCP(C)
Hematologist, Princess Margaret Cancer Centre
Associate Professor of Medicine, University of Toronto
Dr. John Kuruvilla obtained his medical degree from the University of Toronto and followed this with hematology training in British Columbia and a fellowship in lymphoma and stem cell transplantation at the Princess Margaret Cancer Centre. Following his appointment in 2007, he is now an Associate Professor of Medicine at the University of Toronto. Dr. Kuruvilla is currently a Staff Physician in the Division of Medical Oncology and Hematology at Princess Margaret Cancer Centre. He is also a member of many national and international organizations including the Canadian Clinical Trials Group. Dr. Kuruvilla is currently Chair of the Scientific Advisory Board of Lymphoma Canada. His primary area of interest in lymphoma has been in strategies for relapsed or refractory disease including hematopoietic stem cell transplantation and new drug development.